Second-generation fluoroquinolones in the treatment of urogenital chlamydial infection

dc.contributor.authorVasylyeva, K.
dc.contributor.authorBezeha, O.
dc.contributor.authorYemchenko, Y.
dc.contributor.authorKameniev, V.
dc.contributor.authorВасильєва, Катерина Володимирівна
dc.contributor.authorБезега, Олена Вікторівна
dc.contributor.authorЄмченко, Яна Олександрівна
dc.contributor.authorКаменєв, Володимир Іванович
dc.date.accessioned2024-11-22T06:43:15Z
dc.date.available2024-11-22T06:43:15Z
dc.date.issued2024-08-17
dc.description.abstractOur study revealed high clinical efficacy of a second-generation fluoroquinolone drug (sparfloxacin) in the treatment of urogenital chlamydia in combination with cyclophosphine. Sparfloxacin is well tolerated by patients, does not cause general and local toxic and allergic reactions. It is convenient to use: it is prescribed regardless of food intake. We consider it promising to further study the effectiveness of fluoroquinolone antimicrobials in the treatment of other STIs.
dc.identifier.citationSecond-generation fluoroquinolones in the treatment of urogenital chlamydial infection / K. Vasylyeva, O. Bezeha, Y. Yemchenko, V. Kameniev // The 7th International scientific and practical conference «World educational trends: lifelong learning in the information society», (October 15–18, 2024) Athens, Greece. International Science Group. – Athens, 2024. – P. 147–151.
dc.identifier.issn979-8-89504-811-5
dc.identifier.urihttps://repository.pdmu.edu.ua/handle/123456789/25314
dc.language.isoen
dc.publisherInternational Science Group
dc.subjecturogenital chlamydial infection
dc.subjectfluoroquinolone
dc.titleSecond-generation fluoroquinolones in the treatment of urogenital chlamydial infection
dc.typeThesis

Файли

Контейнер файлів
Зараз показуємо 1 - 1 з 1
Ескіз недоступний
Назва:
Vasylyeva_Second_generation_fluoroquinolones.pdf
Розмір:
191.01 KB
Формат:
Adobe Portable Document Format
Ліцензійна угода
Зараз показуємо 1 - 1 з 1
Ескіз недоступний
Назва:
license.txt
Розмір:
4.3 KB
Формат:
Item-specific license agreed upon to submission
Опис: